Allogene Therapeutics competitorsClear all

Allogene Therapeutics's top competitors include Novartis, Amgen, Gilead Sciences, Plus Therapeutics, Cellectis and Legend Biotech.
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background
Allogene Therapeutics
Allogene Therapeutics
Allogene Therapeutics is a clinical stage biotechnology company pioneering the development of allogeneic CAR T therapies for cancer.
Novartis
Novartis
Novartis is a company that researches, develops, manufactures, and markets healthcare products.
Amgen
Amgen
Amgen (formerly known as Applied Molecular Genetics) is a biotech company discovering, developing, manufacturing, and delivering human therapeutics products.
Gilead Sciences
Gilead Sciences
Gilead Sciences is a research-based biopharmaceutical company focused on the discovery, development, and commercialization of medicines.
Plus Therapeutics
Plus Therapeutics
Plus Therapeutics is a pharmaceutical company focused on the development of treatments for patients battling cancer and other life-threatening diseases.
Cellectis
Cellectis
Cellectis is a biopharmaceutical company focused on developing develop a new generation of cancer immunotherapies based on engineered allogeneic T-cells.
Legend Biotech
Legend Biotech
Legend Biotech is a biopharmaceutical company engaged in the discovery and development of cell therapies for oncology and other indications.
Founding Date
Founding Date
2018
Founding Date
1996
Founding Date
1980
Founding Date
1987
Founding Date
1996
Founding Date
1999
Founding Date
2014
Type
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
South San Francisco, US HQ
Locations
Basel, CH HQ
Tirana, AL
Bir Mourad Raïs, DZ
Duc, AR
Macquarie Park, AU
Wien, AT
Baku, AZ
see more
Locations
Thousand Oaks, US HQ
Hydra, DZ
Vicente López, AR
Sydney, AU
Wien, AT
Machelen, BE
Santo Amaro, BR
see more
Locations
Foster City, US HQ
Buenos Aires, AR
Melbourne, AU
Wien, AT
Machelen, BE
São Paulo, BR
Edmonton, CA
see more
Locations
Austin, US HQ
San Antonio, US
Locations
Paris, FR HQ
Lyon, FR
New York, US
Raleigh, US
Locations
Piscataway, US HQ
Nanjing, CN
Nanjing Shi, CN
Dublin, IE
Franklin Township, US
Franklin Township, US
Employees
Employees
2058% increase
Employees
110,0004% increase
Employees
24,200
Employees
14,4006% increase
Employees
12
Employees
272
Employees
650
Valuation ($)
Valuation ($)
1 b
Valuation ($)
N/A
Valuation ($)
137.4 b
Valuation ($)
78.2 b
Valuation ($)
7.4 m
Valuation ($)
140.8 m
Valuation ($)
5.4 b
Twitter followers
Twitter followers
2 k
Twitter followers
299.8 k
Twitter followers
105.3 k
Twitter followers
70.6 k
Twitter followers
320
Twitter followers
4.5 k
Twitter followers
617
Number of tweets (last 30 days)
Number of tweets (last 30 days)
16
Number of tweets (last 30 days)
32
Number of tweets (last 30 days)
136
Number of tweets (last 30 days)
23
Number of tweets (last 30 days)
3
Number of tweets (last 30 days)
10
Number of tweets (last 30 days)
6
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
6.5
Average likes per tweet (last 30 days)
10.8
Average likes per tweet (last 30 days)
5.9
Average likes per tweet (last 30 days)
114.9
Average likes per tweet (last 30 days)
2
Average likes per tweet (last 30 days)
3.1
Average likes per tweet (last 30 days)
2
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
37.5%
Percentage of tweets with engagement (last 30 days)
95.59%
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
100%
Alexa Website Rank
Alexa Website Rank
703432
Alexa Website Rank
102511
Alexa Website Rank
181163
Alexa Website Rank
128868
Alexa Website Rank
244047
Alexa Website Rank
324396
Alexa Website Rank
393967
Employee Rating
Employee Rating
4.4
Employee Rating
4.2
Employee Rating
4.1
Employee Rating
3.8
Employee Rating
2.9
Employee Rating
2.9
Employee Rating
3.5

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
$52.9b (FY, 2021)
Revenue (est.)
$26b (FY, 2021)
Revenue (est.)
$27.3b (FY, 2021)
Revenue (est.)
N/A
Revenue (est.)
$73.9m (FY, 2020)
Revenue (est.)
$75.7m (FY, 2020)
Cost of goods
Cost of goods
N/A
Cost of goods
($9.7b) (FY, 2021)
Cost of goods
$6.5b (FY, 2021)
Cost of goods
$6.6b (FY, 2021)
Cost of goods
N/A
Cost of goods
($39.7m) (FY, 2020)
Cost of goods
N/A
Gross profit
Gross profit
N/A
Gross profit
$45.1b (FY, 2021)
Gross profit
N/A
Gross profit
N/A
Gross profit
N/A
Gross profit
$42.7m (FY, 2020)
Gross profit
N/A
Net income
Net income
($250.2m) (FY, 2020)
Net income
$24b (FY, 2021)
Net income
$5.9b (FY, 2021)
Net income
$6.2b (FY, 2021)
Net income
($8.2m) (FY, 2020)
Net income
($97.5m) (FY, 2020)
Net income
($303.5m) (FY, 2020)

Operating

Countries
Countries
N/A
Countries
N/A
Countries
100 (FY, 2020)
Countries
35 (FY, 2020)
Countries
N/A
Countries
N/A
Countries
N/A
Patents (US)
Patents (US)
N/A
Patents (US)
N/A
Patents (US)
31 (FY, 2020)
Patents (US)
650 (Dec, 2020)
Patents (US)
N/A
Patents (US)
N/A
Patents (US)
N/A
Phase I Trials Products
Phase I Trials Products
4 (FY, 2019)
Phase I Trials Products
N/A
Phase I Trials Products
20 (FY, 2020)
Phase I Trials Products
N/A
Phase I Trials Products
N/A
Phase I Trials Products
N/A
Phase I Trials Products
N/A
Phase III Trials Products
Phase III Trials Products
N/A
Phase III Trials Products
44 (Q4, 2020)
Phase III Trials Products
11 (FY, 2020)
Phase III Trials Products
8 (FY, 2020)
Phase III Trials Products
N/A
Phase III Trials Products
N/A
Phase III Trials Products
N/A
Phase III Trials Products (Oncology)
Phase III Trials Products (Oncology)
N/A
Phase III Trials Products (Oncology)
22 (Q4, 2020)
Phase III Trials Products (Oncology)
N/A
Phase III Trials Products (Oncology)
3 (FY, 2020)
Phase III Trials Products (Oncology)
N/A
Phase III Trials Products (Oncology)
N/A
Phase III Trials Products (Oncology)
N/A

Funding

Total funding raised
Total funding raised
$ 532m
Total funding raised
$ 6.5m
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
$ 71.9m
Total funding raised
$ 3.2m
Total funding raised
$ 150.5m
For sources of this data, please see the company profile

View company profiles

Novartis
HQ
Basel, CH
Employees
110,000↑ 4% increase

Novartis is a company that researches, develops, manufactures, and markets healthcare products.

View company
Amgen
HQ
Thousand Oaks, US
Employees
24,200

Amgen (formerly known as Applied Molecular Genetics) is a biotech company discovering, developing, manufacturing, and delivering human therapeutics products.

View company
Gilead Sciences
HQ
Foster City, US
Employees
14,400↑ 6% increase

Gilead Sciences is a research-based biopharmaceutical company focused on the discovery, development, and commercialization of medicines.

View company
Plus Therapeutics
HQ
Austin, US
Employees
12

Plus Therapeutics is a pharmaceutical company focused on the development of treatments for patients battling cancer and other life-threatening diseases.

View company